OneSource Specialty Pharma Ltd (ONESOURCE) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Neuland Labs.

Astrazeneca Phar

ERIS Lifescience

Natco Pharma

Sai Life

Pfizer

Jubilant Pharmo

Alembic Pharma

Cohance Life

Concord Biotech

OneSource Speci.

Why is OneSource Specialty Pharma Ltd ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

655.90%

EBIT Growth (5y)

243.31%

EBIT to Interest (avg)

0.69

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.19

Sales to Capital Employed (avg)

0.18

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

Pledged Shares

26.04%

Institutional Holding

37.88%

ROCE (avg)

-7.06%

ROE (avg)

2.44%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

134

Industry P/E

Price to Book Value

3.27

EV to EBIT

83.64

EV to EBITDA

39.37

EV to Capital Employed

2.91

EV to Sales

13.44

PEG Ratio

Dividend Yield

ROCE (Latest)

3.48%

ROE (Latest)

2.44%

Loading Valuation Snapshot...

Technicals

Technical key factors

No Data found

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

16What is working for the Company

PAT(9M)

At Rs 112.36 cr has Grown at 245.06%

OPERATING CF(Y)

Highest at Rs -67.85 Cr

NET SALES(9M)

At Rs 1,128.98 cr has Grown at 61.40%

-9What is not working for the Company

PBT LESS OI(Q)

At Rs 2.70 cr has Fallen at -83.6% (vs previous 4Q average

PAT(Q)

At Rs 10.49 cr has Fallen at -56.9% (vs previous 4Q average

NON-OPERATING INCOME(Q)

is 52.96 % of Profit Before Tax (PBT

Loading Valuation Snapshot...

Here's what is working for OneSource Speci.

Net Sales - Nine Monthly

At Rs 1,128.98 cr has Grown at 61.40%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very positive

Net Sales (Rs Cr)

Operating Cash Flow - Annually

Highest at Rs -67.85 Cr and Grown

each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (Rs Cr)

Net Sales - Nine Monthly

Higher at Rs 1,128.98 cr

than preceding 12 month period ended Sep 2025 of Rs 1,092.04 cr

MOJO Watch

In the nine month period the company has already crossed sales of the previous twelve months

Net Sales (Rs Cr)

Here's what is not working for OneSource Speci.

Profit Before Tax less Other Income (PBT) - Quarterly

At Rs 2.70 cr has Fallen at -83.6% (vs previous 4Q average)

over average PBT of the previous four quarters of Rs 16.44 Cr

MOJO Watch

Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly

At Rs 10.49 cr has Fallen at -56.9% (vs previous 4Q average)

over average PAT of the previous four quarters of Rs 24.32 Cr

MOJO Watch

Near term PAT trend is very negative

PAT (Rs Cr)

Non Operating Income - Quarterly

is 52.96 % of Profit Before Tax (PBT)

MOJO Watch

The company's income from non business activities is high; which is not a sustainable business model

Non Operating Income to PBT